Cambodia vs Senegal: Treatment success rate for patients treated for MDR-TB
Cambodia
85.0%
in 2022
Senegal
84.0%
in 2022
Cambodia rank
35th
Senegal rank
38th
Treatment success rate for patients treated for MDR-TB over time
- Cambodia
- Senegal
How they compare
Cambodia currently reports 85.0% against 84.0% in Senegal, a difference of 1.0%.
The two have swapped places 5 times across 12 shared years of data; in 2010 it was Senegal ahead.
Cambodia ranks 35th and Senegal ranks 38th of 163 countries.
Across the 2 decades both report, Cambodia averaged higher in 1 and Senegal in 1.
Head to head by decade
| Decade | Cambodia | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 75.4% | 80.4% | 5.0% | Senegal |
| 2020s | 84.3% | 84.0% | 0.3% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cambodia or Senegal?
- Cambodia, at 85.0% against 84.0% in Senegal as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cambodia and Senegal?
- 1.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Senegal?
- 12 years are reported by both, from 2010 to 2022.
- How do Cambodia and Senegal rank globally for treatment success rate for patients treated for mdr-tb?
- Cambodia ranks 35th and Senegal ranks 38th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.